Position history for HighTower Advisors, LLC's holdings in Inhibrx Biosciences, Inc.
HighTower Advisors, LLC holds 870,507 shares of INBX (Inhibrx Biosciences, Inc.), worth $68.8M as of 2025-Q4. The position was decreased (-0.1% shares). INBX represents 0.1% of HighTower Advisors, LLC's portfolio.
Current Value
$68.8M
Current Shares
870,507
Total Value Change
+$67.2M
Total Shares Change
+763,007
Other major holders of INBX: VIKING GLOBAL INVESTORS LP, MORGAN STANLEY, BlackRock, Inc., VANGUARD GROUP INC
Decreased |
| 870,507 |
-0.1% |
| $68.8M |
| 0.1% |
| $77.98 |
0 |
| 2025-Q3 | Unchanged | 871,759 | 0.0% | $29.4M | 0.0% | $32.31 | 0 |
| 2025-Q2 | Increased | 871,759 | 0.0% | $12.4M | 0.0% | $14.43 | 28 |
| 2025-Q1 | Increased | 871,754 | +11.5% | $12.2M | 0.0% | $14.12 | 31 |
| 2024-Q4 | Increased | 781,752 | +538.2% | $12M | 0.0% | $15.14 | 45 |
| 2024-Q3 | Increased | 122,500 | +13.9% | $1.9M | 0.0% | $15.52 | 29 |
| 2024-Q2 | New | 107,500 | - | $1.5M | 0.0% | $14.17 | 35 |